The American Journal of Managed Care > August 2017
The American Journal of Managed Care - August 2017
August 17, 2017 – Kishan S. Parikh, MD; Kathryn A. Stackhouse, MD; Stephen A. Hart, MD; Thomas M. Bashore, MD; and Richard A. Krasuski, MD
In a multicenter cohort of patients with newly diagnosed pulmonary hypertension, increased risk for mortality among African Americans was no longer observed after adjusting for insurance status.
August 18, 2017 – Shubing Cai, PhD; Patricia A. Laurel, MD; Rajesh Makineni, MS; Mary Lou Marks, RN; Bruce Kinosian, MD; Ciaran S. Phibbs, PhD; and Orna Intrator, PhD
The Hospital-in-Home program implemented at the Veterans Affairs Pacific Islands Health Care System in Honolulu, Hawaii, is associated with reduced costs with no compromise in quality.
August 21, 2017 – Paul Di Capua, MD, MBA, MSHPM; Robin Clarke, MD, MSHS; Chi-Hong Tseng, PhD; Holly Wilhalme, MS; Renee Sednew, MPH; Kathryn M. McDonald, MM, PhD; Samuel A. Skootsky, MD; and Neil Wenger, MD, MPH
A primary care redesign program embedding care coordinators into practices slightly improves the patient experience and does not disrupt team dynamics.
August 22, 2017 – Darius Lakdawalla, PhD; Joanna P. MacEwan, PhD; Robert Dubois, MD, PhD; Kimberly Westrich, MA; Mikel Berdud, PhD; and Adrian Towse, MA, MPhil
This study found that brand price at launch and generic entry overstates long-run average pharmaceutical costs, with and without accounting for medical cost offsets.
TRENDS FROM THE FIELD
August 17, 2017 – Courtland K. Keteyian, MD, MBA, MPH; Brahmajee K. Nallamothu, MD, MPH; and Andrew M. Ryan, PhD
Technology innovation drives expenditures. A Michigan Medicine, IBM, and AirStrip partnership demonstrates the hospitalís role in developing transformative technologies that deliver value.
August 23, 2017 – Seppo T. Rinne, MD, PhD; Meredith C. Graves, PhD; Lori A. Bastian, MD; Peter K. Lindenauer, MD; Edwin S. Wong, PhD; Paul L. Hebert, PhD; and Chuan-Fen Liu, PhD
Among patients admitted for chronic obstructive pulmonary disease (COPD) at Veterans Affairs hospitals, hospital-level length of stay was not associated with 30-day readmission.
August 24, 2017 – Katherine E.M. Miller, MSPH; Wei Duan-Porter, MD, PhD; Karen M. Stechuchak, MS; Elizabeth Mahanna, MPH; Cynthia J. Coffman, PhD; Morris Weinberger, PhD; Courtney Harold Van Houtven, PhD; Eugene Z. Oddone, MD, MHSc; Katina Morris, MS; Kenneth E. Schmader, MD; Cristina C. Hendrix, DNS, GNP-BC; Chad Kessler, MD; and Susan Nicole Hastings, MD, MHSc
The authors examined 2 high-risk classification methods to compare and contrast the patient populations, and to identify the preferred method for predicting subsequent emergency department visits.
August 25, 2017 – Jeffrey C. Yu, AB; Bruce Wolfe, MD; Robert I. Griffiths, ScD, MS; Raul Rosenthal, MD; Daniel Cohen, MA; and Iris Lin, PhD
This lifetime economic analysis demonstrates vagal nerve blocking therapy to be a cost-effective alternative to conventional therapy in class 2 and 3 obesity patients.
August 26, 2017 – Xian Shen, PhD; Bruce C. Stuart, PhD; Christopher A. Powers, PharmD; Sarah E. Tom, PhD, MPH; Laurence S. Magder, PhD; and Eleanor M. Perfetto, PhD, MS
Placing formulary restrictions on brand name drugs shifts use toward generics, lowers the cost per prescription fill, and has minimal impact on overall adherence for antidiabetes, antihyperlipidemia, and antihypertension medications among low-income subsidy recipients in Medicare Part D plans.
August 28, 2017 – Taiwo Adesoye, MD, MPH; Linda G. Kimsey, PhD, MSc; Stuart R. Lipsitz, SCD; Louis L. Nguyen, MD, MBA, MPH; Philip Goodney, MD; Samuel Olaiya, PhD; and Joel S. Weissman, PhD
Geographic variation in healthcare spending and utilization within the Military Health System is higher and significantly correlated with Medicare across hospital referral regions.